Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Filetype[PDF-25.30 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Details:
  • Supporting Files:
    No Additional Files
This document has replaced (most recent first):
  1. Filetype[PDF - 179.37 KB]
    Personal Author:
    Rosenstein, Nancy E.; Perkins, Bradley A.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..
    Published Date:
    June 30, 2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-7):1-10.
    Description:
    This report summarizes and updates an earlier published statement issued by the Advisory Committee on Immunization Practices concerning the control and prevention of meningococcal disease (MMWR 1997:46[No. RR-5]:1-21) and provides updated recommendat...
    Status:
    superseded
    File Type:
    Filetype[PDF - 179.37 KB]
  2. Filetype[PDF - 515.21 KB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    August 10, 2007
    Source:
    MMWR. Morbidity and mortality weekly report. 2007; 56(31):794-5.
    Description:
    In January 2005, a quadrivalent meningococcal polysaccharide- protein conjugate vaccine (MCV4) (Menactra™, Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11–55 years. In May 2005, the Advisory Committee on...
    Status:
    superseded
    File Type:
    Filetype[PDF - 515.21 KB]
  3. Filetype[PDF - 321.91 KB]
    Personal Author:
    Bilukha, Oleg; Rosenstein, Nancy E.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..
    Published Date:
    May 27, 2005
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-7
    Description:
    "In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11-55 years. CDCns Advisory Committee on ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 321.91 KB]
  4. Filetype[PDF - 64.63 KB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    October 14, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(40):1391-2.
    Description:
    In April 2011, the Food and Drug Administration approved the use of a quadrivalent meningococcal conjugate vaccine (MenACWY-D) (Menactra, Sanofi Pasteur) as a 2-dose primary series among children aged 9 through 23 months (1). Vaccination with meningo...
    Status:
    superseded
    File Type:
    Filetype[PDF - 64.63 KB]
  5. Filetype[PDF - 1.49 MB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    September 25, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(37):1042-3.
    Description:
    The Advisory Committee on Immunization Practices (ACIP) recommends quadrivalent meningococcal conjugate vaccine, (MCV4) (Menactra, Sanofi Pasteur, Swiftwater, Pennsylvania) for all persons aged 11-18 years and for persons aged 2-55 years at increased...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.49 MB]
  6. Filetype[PDF - 72.15 KB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    August 11, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(30):1018-9.
    Description:
    In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics), a quadrivalent meningococcal conjugate vaccine, to include persons aged 2 through 55 years. One other...
    Status:
    superseded
    File Type:
    Filetype[PDF - 72.15 KB]
  7. Filetype[HTM]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    February 14, 1997
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):1-10.
    Description:
    These recommendations update information regarding the polysaccharide vaccine licensed in the United States for use against disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135, as well as antimicrobial agents for chemoprophylaxis a...
    Status:
    superseded
    File Type:
    Filetype[HTM]
  8. Filetype[PDF - 179.37 KB]
    Personal Author:
    Rosenstein, Nancy E.; Perkins, Bradley A.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..
    Published Date:
    June 30, 2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-7):13-20.
    Description:
    This report provides information regarding the modestly increased risk for meningococcal disease among college freshmen, particularly those who live in dormitories or residence halls. It presents recommendations developed by the Advisory Committee on...
    Status:
    superseded
    File Type:
    Filetype[PDF - 179.37 KB]
  9. Filetype[HTM]
    Published Date:
    May 2, 2008
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(17):462-5.
    Description:
    At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine vaccination of children aged 2--10 years against meningococcal disease unless the child is at increased risk for the disease. This ...
    Status:
    superseded
    File Type:
    Filetype[HTM]
  10. Filetype[HTM]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    January 28, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(3):72-6.
    Description:
    On October 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroups A, C, Y, and W-135) meningococcal conjugate vaccines (Menveo, Novartis; and Menactra, Sanofi Pasteur...
    Status:
    superseded
    File Type:
    Filetype[HTM]
  11. Filetype[HTM]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    February 14, 1997
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):13-21.
    Description:
    Outbreaks of serogroup C meningococcal disease (SCMD) have been occurring more frequently in the United States since the early 1990s, and the use of vaccine to control these outbreaks has increased. These outbreaks are characterized by increased rate...
    Status:
    superseded
    File Type:
    Filetype[HTM]
  12. Filetype[PDF - 1.59 MB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    March 12, 2010
    Source:
    MMWR. Morbidity and mortality weekly report. 2010; 59(9):273.
    Description:
    On February 19, 2010, the Food and Drug Administration (FDA) licensed a quadrivalent meningococcal conjugate vaccine, MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics). MenACWY-CRM is licensed as a single dose for use among persons aged 11-55 y...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.59 MB]

You May Also Like:

  1. Filetype[PDF - 705.38 KB]
    Personal Author:
    Dowell, Deborah; Haegerich, Tamara M.; Chou, Roger;
    Corporate Authors:
    National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention.
    Published Date:
    March 18, 2016
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 65, no. 1
    Description:
    This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses 1) when to initiate or continue opioid...
    Status:
    current
    File Type:
    Filetype[PDF - 705.38 KB]
  2. Filetype[PDF - 642.56 KB]
    Personal Author:
    Briere, Elizabeth C.; Rubin, Lorry; Moro, Pedro L.; Cohn, Amanda C.; Clark, Thomas A.; Messonnier, Nancy E.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases..
    Published Date:
    February 28, 2014
    Source:
    MMWR Recomm Rep. 2014 Feb 28;63(RR-01):1-14.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 63, RR-01
    Description:
    This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of Haemophilus influenzae type b (Hib) disease in the United States. As a comprehensive summary of...
    Status:
    current
    File Type:
    Filetype[PDF - 642.56 KB]
  3. Filetype[PDF - 490.22 KB]
    Personal Author:
    Evans, Shelley; McKenzie, Jeannie; Shannon, Barbara; Wechsler, Howell;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    June 14, 1996
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; 45, no. RR-9
    Description:
    "Healthy eating patterns in childhood and adolescence promote optimal childhood health, growth, and intellectual development; prevent immediate health problems, such as iron deficiency anemia, obesity, eating disorders, and dental caries; and ma...
    Status:
    superseded
    File Type:
    Filetype[PDF - 490.22 KB]
  4. Filetype[PDF - 683.29 KB]
    Personal Author:
    Grohskopf, Lisa A.; Shay, David K.; Shimabukuro, Tom T.; Sokolow, Leslie Z.; Keitel, Wendy A.; Bresee, Joseph S.; Cox, Nancy (Nancy J.);
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.. United States. Advisory Committee on Immunization Practices..
    Published Date:
    September 20, 2013
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, RR-07
    Description:
    This report updates the 2012 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccines for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza with vacc...
    Status:
    superseded
    File Type:
    Filetype[PDF - 683.29 KB]
  5. Filetype[PDF - 879.66 KB]
    Personal Author:
    Curtis, Kathryn M.; Jatlaoui, Tara C.; Tepper, Naomi K.; Zapata, Lauren B.; Horton, Leah G.; Jamieson, Denise J.; Whiteman, Maura K.;
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Reproductive Health.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    July 29, 2016
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 65, no.4
    Description:
    The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations ...
    Status:
    current
    File Type:
    Filetype[PDF - 879.66 KB]